These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7663658)

  • 41. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
    Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
    Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G; Hoffjan S; Mosler K; Schuster A
    Lung; 2001; 179(3):185-94. PubMed ID: 11891608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Hodson ME
    Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
    App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
    Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological approaches to discovery and development of new mucolytic agents.
    King M; Rubin BK
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1475-90. PubMed ID: 12458156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
    Durward A; Forte V; Shemie SD
    Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
    Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R; de Jongste JC; Merkus PJ
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
    Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
    Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL; Scott SF; Fuchs HJ; Geddes DM; Hodson ME
    Thorax; 1995 Apr; 50(4):333-8. PubMed ID: 7785003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y; Wills PJ; Cole PJ
    Respiration; 2001; 68(6):615-9. PubMed ID: 11786718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
    Martin R; Litt M; Marriott C
    Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental models for studying mucociliary clearance.
    King M
    Eur Respir J; 1998 Jan; 11(1):222-8. PubMed ID: 9543296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.
    Ma JT; Tang C; Kang L; Voynow JA; Rubin BK
    Chest; 2018 Aug; 154(2):370-377. PubMed ID: 29559310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
    Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A parametric study of mucociliary transport by numerical simulations of 3D non-homogeneous mucus.
    Chatelin R; Poncet P
    J Biomech; 2016 Jun; 49(9):1772-1780. PubMed ID: 27126985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.